Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Neural Transm (Vienna). 2015 Nov;122(11):1541-6. doi: 10.1007/s00702-015-1433-1. Epub 2015 Jul 30.

Early Parkinson's disease patients on rasagiline present with better odor discrimination.

Author information

  • 1Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, 01307, Dresden, Germany. antje.haehner@uniklinikum-dresden.de.
  • 2Smell and Taste Clinic, Department of Otorhinolaryngology, TU Dresden, 01307, Dresden, Germany.
  • 3Department of Neurology, TU Dresden, Dresden, Germany.
  • 4Division of Neurodegenerative Diseases, Department of Neurology, TU Dresden, Dresden, Germany.
  • 5German Centre for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany.

Abstract

The effects of rasagiline on olfaction in animal studies are convincing. However, apart from various anecdotal patient reports, they could not be reproduced in prospective studies in humans. Cross-sectional data of large patient groups are still missing. The aim of this study was therefore to determine the olfactory function in a broad heterogeneous Parkinson's disease (PD) population with and without rasagiline intake. In this single-center, cross-sectional study 224 PD patients with and without rasagiline (1 mg/day) participated. Seventy-four of them received rasagiline as mono, or adjunct therapy. One-hundred fifty patients were untreated or received PD medication other than rasagiline. Comprehensive olfactory testing was performed for phenyl-ethyl alcohol odor thresholds, odor discrimination, and odor identification. Olfactory function did not differ between the two treatment groups with disease duration up to 29 years. Rasagiline-treated patients with disease duration of less than 8 years, however, presented with significant better odor discrimination abilities compared to PD patients without rasagiline treatment. This effect was no longer evident in patients with longer disease duration and proofed to be independent of age, sex, and medication. Our results may suggest that rasagiline treatment has a positive effect on the processing of olfactory information in early PD.

KEYWORDS:

Olfaction; Parkinson’s disease; Rasagiline; Smell

PMID:
26224038
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk